vs
凯雷集团（CG）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
凯雷集团的季度营收约是瑞思迈的1.3倍（$1.9B vs $1.4B），瑞思迈净利率更高（27.6% vs 18.8%，领先8.8%），凯雷集团同比增速更快（84.1% vs 11.0%），过去两年凯雷集团的营收复合增速更高（66.2% vs 7.8%）
凯雷集团是美国知名跨国企业，核心业务涵盖私募股权投资、另类资产管理及金融服务领域。截至2023年，公司管理资产总规模达4260亿美元，是全球另类资管行业的重要参与者。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CG vs RMD — 直观对比
营收规模更大
CG
是对方的1.3倍
$1.4B
营收增速更快
CG
高出73.2%
11.0%
净利率更高
RMD
高出8.8%
18.8%
两年增速更快
CG
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.4B |
| 净利润 | $358.1M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 24.3% | 34.6% |
| 净利率 | 18.8% | 27.6% |
| 营收同比 | 84.1% | 11.0% |
| 净利润同比 | 69.8% | 13.9% |
| 每股收益（稀释后） | $0.96 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CGRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $332.7M | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $973.1M | $1.3B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $2.6B | $1.2B |
净利润CGRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $358.1M | $392.6M | ||
| Q3 25 | $900.0K | $348.5M | ||
| Q2 25 | $319.7M | $379.7M | ||
| Q1 25 | $130.0M | $365.0M | ||
| Q4 24 | $210.9M | $344.6M | ||
| Q3 24 | $595.7M | $311.4M |
毛利率CGRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
营业利润率CGRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 24.3% | 34.6% | ||
| Q3 25 | 25.8% | 33.4% | ||
| Q2 25 | 28.0% | 33.7% | ||
| Q1 25 | 17.6% | 33.0% | ||
| Q4 24 | 25.7% | 32.5% | ||
| Q3 24 | 29.9% | 31.6% |
净利率CGRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 18.8% | 27.6% | ||
| Q3 25 | 0.3% | 26.1% | ||
| Q2 25 | 20.3% | 28.2% | ||
| Q1 25 | 13.4% | 28.3% | ||
| Q4 24 | 20.4% | 26.9% | ||
| Q3 24 | 22.6% | 25.4% |
每股收益（稀释后）CGRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $0.96 | $2.68 | ||
| Q3 25 | $0.00 | $2.37 | ||
| Q2 25 | $0.87 | $2.58 | ||
| Q1 25 | $0.35 | $2.48 | ||
| Q4 24 | $0.56 | $2.34 | ||
| Q3 24 | $1.63 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0B | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $7.1B | $6.3B |
| 总资产 | $29.1B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资CGRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.0B | $1.4B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $932.7M | ||
| Q4 24 | $1.3B | $521.9M | ||
| Q3 24 | $1.4B | $426.4M |
总债务CGRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益CGRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $7.1B | $6.3B | ||
| Q3 25 | $6.8B | $6.1B | ||
| Q2 25 | $6.7B | $6.0B | ||
| Q1 25 | $6.4B | $5.5B | ||
| Q4 24 | $6.3B | $5.3B | ||
| Q3 24 | $6.3B | $5.2B |
总资产CGRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $29.1B | $8.5B | ||
| Q3 25 | $27.1B | $8.3B | ||
| Q2 25 | $25.1B | $8.2B | ||
| Q1 25 | $24.1B | $7.6B | ||
| Q4 24 | $23.1B | $7.1B | ||
| Q3 24 | $22.7B | $7.2B |
负债/权益比CGRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2B | — |
| 自由现金流经营现金流 - 资本支出 | $-1.2B | — |
| 自由现金流率自由现金流/营收 | -65.1% | — |
| 资本支出强度资本支出/营收 | 2.2% | — |
| 现金转化率经营现金流/净利润 | -3.34× | — |
| 过去12个月自由现金流最近4个季度 | $-3.4B | — |
8季度趋势，按日历期对齐
经营现金流CGRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $339.7M | ||
| Q3 25 | $-1.6B | $457.3M | ||
| Q2 25 | $-168.8M | $538.8M | ||
| Q1 25 | $-352.1M | $578.7M | ||
| Q4 24 | $-352.8M | $308.6M | ||
| Q3 24 | $791.9M | $325.5M |
自由现金流CGRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-1.2B | $311.2M | ||
| Q3 25 | $-1.6B | $414.4M | ||
| Q2 25 | $-186.3M | $508.2M | ||
| Q1 25 | $-368.8M | $557.9M | ||
| Q4 24 | $-379.5M | $288.0M | ||
| Q3 24 | $772.8M | $307.7M |
自由现金流率CGRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -65.1% | 21.9% | ||
| Q3 25 | -475.7% | 31.0% | ||
| Q2 25 | -11.8% | 37.7% | ||
| Q1 25 | -37.9% | 43.2% | ||
| Q4 24 | -36.8% | 22.5% | ||
| Q3 24 | 29.3% | 25.1% |
资本支出强度CGRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 2.2% | 2.0% | ||
| Q3 25 | 7.0% | 3.2% | ||
| Q2 25 | 1.1% | 2.3% | ||
| Q1 25 | 1.7% | 1.6% | ||
| Q4 24 | 2.6% | 1.6% | ||
| Q3 24 | 0.7% | 1.5% |
现金转化率CGRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -3.34× | 0.87× | ||
| Q3 25 | -1732.78× | 1.31× | ||
| Q2 25 | -0.53× | 1.42× | ||
| Q1 25 | -2.71× | 1.59× | ||
| Q4 24 | -1.67× | 0.90× | ||
| Q3 24 | 1.33× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |
RMD
暂无分部数据
